CTRI/2020/12/029739
Completed
Phase 3
A multicentric, randomized, double-blind, parallel, comparative study to demonstrate the non-inferiority of fixed-dose combination of Efonidipine 40 mg and Telmisartan 40 mg tablets to fixed-dose combination of Cilnidipine 10 mg and Telmisartan 40 mg tablets in the management of patients with Stage II hypertension.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Zuventus Healthcare Limited
- Enrollment
- 240
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults (aged \>\=18 years) treatment naïve patients.
- •2\. Patients diagnosed with Stage\-II hypertension (SBP/DBP: \>\=160/100 mmHg)
- •3\. Patients willing to sign informed consent
Exclusion Criteria
- •1\. Patients with known hypersensitivity to angiotensin II receptor blockers or dihydropyridine calcium channel blockers.
- •2\. Patients with history of severe, malignant or secondary hypertension.
- •3\. Patient with cerebrovascular disease in the previous 3 months.
- •4\. Patients with chronic arrhythmia, sick sinus syndrome or sinus bradycardia ( \< 50 beats/min).
- •5\. Patients with second\- or third\-degree atrioventricular block.
- •6\. Female patients who are pregnant, lactating.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Comparison of Efonidipine 40 mg and Chlorthalidone 12.5 mg combination tablets versus Cilnidipine 10 mg and Chlorthalidone 12.5 mg combination tablets in the management of high blood pressure.CTRI/2020/08/027364Zuventus Healthcare Limited240
Completed
Phase 3
A Phase III clinical study to compare efficacy and safety of Efonidipine and S(-)Metoprolol combination when compared to Cilnidipine and Metoprolol combination in patients with high blood pressure.CTRI/2020/12/029740Zuventus Healthcare Limited240
Active, not recruiting
Phase 1
The purpose of this study is to determine whether CBT124 and Avastin®are comparable in terms of efficacy, safety, immunogenicity; and whether the pharmacokinetics of CBT124 matches that of Avastin®(pharmacokinetics is nested in this study for Indian patients).EUCTR2016-003301-34-BGCipla BioTec Pvt. Ltd.200
Not yet recruiting
Phase 3
Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel versus DUAC® Gel versus Placebo in Patients with Acne VulgarisCTRI/2015/11/006379Cadila Healthcare Limited850
Completed
Not Applicable
A study to check effectiveness of Adapalene and Benzoyl peroxide Gel in patients with Acne VulgarisCTRI/2019/01/017297Morningside Healthcare Ltd550